Aquestive director granted 50,500 stock options
Aquestive Therapeutics director Marco Taglietti received a grant of stock options covering 50,500 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Aquestive Therapeutics director Marco Taglietti received a grant of stock options covering 50,500 shares of common stock. These options have an exercise price of $3.99 per share and expire on June 10, 2036. All 50,500 underlying shares vest on June 10, 2027, if he remains in continuous service through that date.
Insider Trade Summary
Grant/Award: 50,500 shares
Grant/Award
1 txn
Insider
Taglietti Marco
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Purchase) | 50,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Purchase) — 50,500 contracts (Direct)
Footnotes (1)
- F1. The shares underlying the options vest as follows: 100% of the underlying shares vest June 10, 2027, subject to Dr. Taglietti's continuous service with the Issuer from the grant date through the applicable vesting date.
Key Figures
Options granted: 50,500 options
Exercise price: $3.99 per share
Underlying shares: 50,500 shares
+2 more
5 metrics
Options granted
50,500 options
Grant of stock options to Marco Taglietti on June 10, 2026
Exercise price
$3.99 per share
Stock option exercise price for underlying common stock
Underlying shares
50,500 shares
Common stock underlying the stock option award
Vesting date
June 10, 2027
100% of underlying shares vest on this date with continuous service
Expiration date
June 10, 2036
Option expiration for the granted stock options
Key Terms
Stock Option (Right to Purchase), exercise price, expiration date, vest, +1 more
5 terms
Stock Option (Right to Purchase) financial
"security_title: Stock Option (Right to Purchase)"
exercise price financial
"conversion_or_exercise_price: 3.9900"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-10T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vest financial
"100% of the underlying shares vest June 10, 2027"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
derivative securities financial
"transaction_type: derivative"
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Aquestive Therapeutics (AQST) report in Marco Taglietti’s latest Form 4?
Aquestive Therapeutics reported that director Marco Taglietti received a grant of stock options on June 10, 2026, for 50,500 shares of common stock. The filing details the exercise price, vesting schedule, and expiration date for this new equity award.
How many stock options did Marco Taglietti receive from Aquestive Therapeutics (AQST)?
Marco Taglietti received stock options covering 50,500 shares of Aquestive Therapeutics common stock. This derivative award was reported as a grant under transaction code A and represents his post-transaction derivative holdings according to the Form 4 data provided.
What is the exercise price of Marco Taglietti’s new Aquestive Therapeutics (AQST) options?
The new stock options granted to Marco Taglietti have an exercise price of $3.99 per share. This means he can purchase common stock at $3.99 once the options vest, subject to the terms and conditions disclosed for this award.
When do Marco Taglietti’s Aquestive Therapeutics (AQST) stock options vest and expire?
All 50,500 underlying shares vest on June 10, 2027, if Marco Taglietti maintains continuous service with Aquestive Therapeutics through that date. The options then remain exercisable until their stated expiration on June 10, 2036, according to the Form 4 footnote.
Is Marco Taglietti’s Form 4 transaction in Aquestive Therapeutics (AQST) a purchase or a grant?
The Form 4 reports a grant of stock options, not an open-market share purchase. The transaction is coded “A” for grant, award, or other acquisition and is described as a grant/award acquisition of derivative securities rather than a buy on the public market.
What conditions apply to the vesting of Marco Taglietti’s Aquestive Therapeutics (AQST) options?
Vesting of Marco Taglietti’s options requires continuous service with Aquestive Therapeutics. The footnote states that 100% of the underlying 50,500 shares vest on June 10, 2027, provided he remains in service from the grant date through that vesting date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates